Search

Kelly Jack Mcclure

from Ramona, CA
Age ~53
Get Report
Also known as:
Kelly J Mcclure, Kelly K Mcclure, Kelly M Mcclure, Kelly Mc Clure, Kelly Jack Mc Clure, Kelly J Mc, Kelly Amy
Phone and address:
17012 Arena Way, Ramona, CA 92065
(760) 440-9987
Related to:
Frankie M Mcclure, 74Tom Mccabe, 73Raymond W McgarrCameron SparrJames P Mcgrogan, 46
Connected to:
Ammber N Mcclure, 40Anjalea L Mcclurg, 47Arlandra Mcclure, 64Asha B Mcclurg, 39Aundeanea W Mcclure, 54Bonnie L Mcclure, 60Bonnie J Mcclurg, 64Bonny L Mcclure, 53Breanna Mcclure, 29Brooklyn T Mcclure, 29

Kelly Mcclure Phones & Addresses

  • 17012 Arena Way, Ramona, CA 92065 (760) 440-9987
  • 3050 Science Park Rd, San Diego, CA 92121
  • 2520 Chicago St, San Diego, CA 92110 (619) 276-7642
  • Tucson, AZ
  • 1175 Harmony Rd, Iowa Park, TX 76367 (940) 592-2503

Work

Company: drivers, Logistics, LLC Oct 2011 to Apr 2012 Address: Atlanta, GA Specialities: Manager

Specialities

International Law • Appeals • Litigation

Professional Records

Medicine Doctors

Kelly Mcclure Photo 1

Kelly Mcclure

View page
Specialties:
Family Medicine
Work:
University Health Center
600 S College Ave Uhc229, Warrensburg, MO 64093
(660) 543-4773 (phone)
Languages:
English
Description:
Ms. Mcclure works in Warrensburg, MO and specializes in Family Medicine. Ms. Mcclure is affiliated with Lees Summit Medical Center and Western Missouri Medical Center.

License Records

Kelly James Mcclure

Address:
7640 Stalmer St #107, San Diego, CA 92111
License #:
2283 - Expired
Issued Date:
May 11, 2004
Renew Date:
May 11, 2004
Expiration Date:
Aug 31, 2006
Type:
Respiratory Therapist

Kelly L Mcclure

License #:
4914 - Expired
Category:
Nursing Home Administrator
Issued Date:
Jan 1, 2002

Lawyers & Attorneys

Kelly Mcclure Photo 2

Kelly Mcclure - Lawyer

View page
Office:
Nutter McClennen & Fish LLP
Specialties:
International Law
Appeals
Litigation
ISLN:
921702557
Admitted:
2010
University:
Boston College, B.A.
Law School:
Boston College Law School, J.D.

Publications

Us Patents

Cck-1 Receptor Modulators

View page
US Patent:
7037931, May 2, 2006
Filed:
Jul 2, 2003
Appl. No.:
10/612150
Inventors:
Terrance D. Barrett - Encinitas CA, US
J. Guy Breitenbucher - Escondido CA, US
Laurent Gomez - San Diego CA, US
Michael D. Hack - San Diego CA, US
Liming Huang - San Diego CA, US
Kelly J. McClure - San Diego CA, US
Magda F. Morton - San Diego CA, US
Clark A. Sehon - West Chester PA, US
Nigel P. Shankley - Solana Beach CA, US
Assignee:
Janssen Pharmaceutica N.V.
International Classification:
A61K 31/415
C07D 231/10
US Classification:
514406, 5483761
Abstract:
There are provided by the present invention certain pyrazole based CCK-1 receptor modulators.

Substituted Benzimidazoles And Imidazo-[4,5]-Pyridines

View page
US Patent:
7271261, Sep 18, 2007
Filed:
Oct 18, 2002
Appl. No.:
10/273487
Inventors:
Kristen L. Arienti - La Mesa CA, US
Frank U. Axe - Escondido CA, US
J. Guy Breitenbucher - Escondido CA, US
Liming Huang - San Diego CA, US
Alice Lee - San Diego CA, US
Kelly J. McClure - San Diego CA, US
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
C07D 235/18
C07D 471/04
C07D 401/04
A61K 31/4184
US Classification:
544139, 544364, 544370, 5462734, 5483097, 5483101, 5483104, 5483107, 5483117
Abstract:
2-Aryl substituted benzimidazoles and imidazo[4,5]pyridines are disclosed as inhibitors of Cds1 and useful as adjuvants to chemotherapy or radiation therapy in the treatment of cancer.

Cck-1 Receptor Modulators

View page
US Patent:
7465808, Dec 16, 2008
Filed:
Sep 19, 2005
Appl. No.:
11/230200
Inventors:
Terrance D. Barrett - Encinitas CA, US
J. Guy Breitenbucher - Escondido CA, US
Laurent Gomez - San Diego CA, US
Michael D. Hack - San Diego CA, US
Liming Huang - San Diego CA, US
Kelly J. McClure - San Diego CA, US
Magda F. Morton - San Diego CA, US
Clark A. Sehon - West Chester PA, US
Nigel P. Shankley - Solana Beach CA, US
Assignee:
Janssen Pharmaceutica, N.V. - Beerse
International Classification:
C07D 231/12
A61K 31/415
A61K 31/4155
US Classification:
5483771, 5483641, 5483644, 514406
Abstract:
There are provided by the present invention certain pyrazole based CCK-1 receptor modulators.

Substituted Benzimidazoles And Imidazo-[4,5]-Pyridines

View page
US Patent:
7504414, Mar 17, 2009
Filed:
Aug 2, 2007
Appl. No.:
11/832789
Inventors:
Kristen L. Arienti - La Mesa CA, US
Frank U. Axe - Escondido CA, US
J. Guy Breitenbucher - Escondido CA, US
Liming Huang - San Diego CA, US
Alice Lee - San Diego CA, US
Kelly J. McClure - San Diego CA, US
Assignee:
Ortho-McNeil Pharmaceutical, Inc. - Raritan NJ
International Classification:
C07D 487/04
A61K 31/4188
US Classification:
514303, 546118
Abstract:
2-Aryl substituted benzimidazoles and imidazo[4,5]pyridines are disclosed as inhibitors of Cds1 and useful as adjuvants to chemotherapy or radiation therapy in the treatment of cancer.

Aryl-Substituted Bridged Or Fused Diamines As Modulators Of Leukotriene A Ydrolase

View page
US Patent:
8344008, Jan 1, 2013
Filed:
Apr 21, 2011
Appl. No.:
13/091498
Inventors:
Genesis M. Bacani - San Diego CA, US
Scott D. Bembenek - San Diego CA, US
Wendy Eccles - San Diego CA, US
James P. Edwards - San Diego CA, US
Matthew T. Epperson - San Diego CA, US
Laurent Gomez - San Diego CA, US
Cheryl A. Grice - Carlsbad CA, US
Aaron M. Kearney - Lakeside CA, US
Adrienne M. Landry-Bayle - Carlsbad CA, US
Kelly J. McClure - Ramona CA, US
Taraneh Mirzadegan - San Diego CA, US
Alexandro Santillán, Jr. - San Diego CA, US
Assignee:
Janssen Pharmaceutica NV - Beerse
International Classification:
A61K 31/425
US Classification:
514367, 548159, 548560, 548950, 549 59, 549429
Abstract:
Aryl-substituted bridged or fused diamine compounds, pharmaceutical compositions containing them, and methods of using the compounds and the pharmaceutical compositions for leukotriene Ahydrolase (LTAH or LTA4H) modulation and for the treatment of disease states, disorders, and conditions mediated by LTAH activity, such as allergy, asthma, autoimmune diseases, pruritis, inflammatory bowel disease, ulcerative colitis, and cardiovascular disease, including atherosclerosis and prevention of myocardial infarction.

Aryl-Substituted Bridged Or Fused Diamines As Modulators Of Leukotriene Ahydrolase

View page
US Patent:
8367719, Feb 5, 2013
Filed:
Apr 21, 2011
Appl. No.:
13/091772
Inventors:
Genesis M. Bacani - San Diego CA, US
Scott D. Bembenek - San Diego CA, US
Wendy Eccles - San Diego CA, US
James P. Edwards - San Diego CA, US
Laurent Gomez - San Diego CA, US
Cheryl A. Grice - Carlsbad CA, US
Aaron M. Kearney - Lakeside CA, US
Adrienne M. Landry-Bayle - Carlsbad CA, US
Kelly J. McClure - Ramona CA, US
Taraneh Mirzadegan - San Diego CA, US
Alejandro Santillán, Jr. - San Diego CA, US
Assignee:
Janssen Pharmaceutica NV - Beerse
International Classification:
A61K 31/34
US Classification:
514469, 548217
Abstract:
Aryl-substituted bridged or fused diamine compounds, pharmaceutical compositions containing them, and methods of using the compounds and the pharmaceutical compositions for leukotriene Ahydrolase (LTAH or LTA4H) modulation and for the treatment of disease states, disorders, and conditions mediated by LTAH activity, such as allergy, asthma, autoimmune diseases, pruritis, inflammatory bowel disease, ulcerative colitis, and cardiovascular disease, including atherosclerosis and prevention of myocardial infarction.

Tetrahydro-Pyrimidoazepines As Modulators Of Trpv1

View page
US Patent:
20070225275, Sep 27, 2007
Filed:
Mar 21, 2007
Appl. No.:
11/726756
Inventors:
Brett Allison - Del Mar CA, US
Bryan Branstetter - Carlsbad CA, US
James Breitenbucher - Escondido CA, US
Michael Hack - San Diego CA, US
Natalie Hawryluk - San Diego CA, US
Alec Lebsack - San Diego CA, US
Kelly McClure - Ramona CA, US
Jeffrey Merit - San Diego CA, US
International Classification:
A61K 31/55
C07D 487/02
US Classification:
514215000, 540578000
Abstract:
Certain tetrahydro-pyrimidoazepine compounds are described, which are useful as TRPV1 modulators. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by TRPV1. Thus, the compounds may be-administered to treat, e.g., pain, itch, cough, asthma, or inflammatory bowel disease.

Aryl-Substituted Bridged Or Fused Diamines As Modulators Of Leukotriene A4 Hydrolase

View page
US Patent:
20090111794, Apr 30, 2009
Filed:
Oct 30, 2008
Appl. No.:
12/291018
Inventors:
Genesis M. Bacani - San Diego CA, US
Scott D. Bembenek - San Diego CA, US
Wendy Eccles - San Diego CA, US
James P. Edwards - San Diego CA, US
Matthew T. Epperson - San Diego CA, US
Laurent Gomez - San Diego CA, US
Cheryl A. Grice - Carlsbad CA, US
Aaron M. Kearney - Lakeside CA, US
Adrienne M. Landry-Bayle - Carlsbad CA, US
Kelly J. McClure - Ramona CA, US
Taraneh Mirzadegan - San Diego CA, US
Alejandro Santillan, JR. - San Diego CA, US
International Classification:
A61K 31/55
C07D 277/68
C07D 263/54
C07D 487/08
A61K 31/423
A61K 31/4439
A61P 37/02
A61K 31/497
A61K 31/428
C07D 401/14
C07D 417/14
US Classification:
51421402, 548165, 548217, 540580, 544405, 5462701, 514367, 514375, 51425505, 514338
Abstract:
Aryl-substituted bridged or fused diamine compounds, pharmaceutical compositions containing them, and methods of using the compounds and the pharmaceutical compositions for leukotriene Ahydrolase (LTAH or LTA4H) modulation and for the treatment of disease states, disorders, and conditions mediated by LTAH activity, such as allergy, asthma, autoimmune diseases, pruritis, inflammatory bowel disease, ulcerative colitis, and cardiovascular disease, including atherosclerosis and prevention of myocardial infarction.
Control profile
Kelly Jack Mcclure from Ramona, CA, age ~53 Get Report